Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05839093
Other study ID # TDH-2020-12818
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 21, 2021
Est. completion date March 14, 2022

Study information

Verified date May 2023
Source Cukurova University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this clinical study is to evaluate the success of buccal infiltration (BI) anesthesia + intraligamentary (ILI) anesthesia between inferior alveolar nerve block (IANB) anesthesia + buccal infiltration anesthesia in mandibular molar teeth with acute symptomatic irreversible pulpitis.The main questions it aims to answer are: - Does the anesthesia techniques adequate to perform root canal treatment painlessly? - Which technique achieved pulpal anesthesia? Participants were allocated in two groups according to the randomization blocks, with a total of 25 patients in each group. In IANB + BI anesthesia techniques, a total of approximately 2.8 ml of anesthetic solution, 1.8 ml + 1 ml, was applied, while for BI + ILI, a total of approximately 1.72 ml, 1 ml + 0.72 ml, was administered. Then, root canal treatment was performed. Researchers were compared the success of anesthesia techniques in different stages of root canal treatment.


Description:

A total of 50 patients, aged between 18-65, who were diagnosed with symptomatic irreversible pulpitis of the mandibular molar tooth, were included in this study. The patients were allocated in two groups according to the randomization blocks, with a total of 25 patients in each group. In IANB + BI anesthesia techniques, a total of approximately 2.8 ml of anesthetic solution, 1.8 ml + 1 ml, was applied, while for BI + ILI, a total of approximately 1.72 ml, 1 ml + 0.72 ml, was administered. After the anesthesia, a rubber dam was placed on the associated tooth of the patient for root canal treatment, the endodontic access cavity was opened, and canal preparation procedures were started. The pain levels felt by the patients during the endodontic treatment stages (starting the treatment, opening the endodontic access cavity and pulp extirpation) were determined by Heft-Parker VAS (HP-VAS) scale. Anesthesia was considered successful in patients who felt no pain (HP-VAS ratio = 0) or mild pain (HP-VAS ratio ≤ 54) during the procedures.


Recruitment information / eligibility

Status Completed
Enrollment 210
Est. completion date March 14, 2022
Est. primary completion date March 3, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: 1. Systemically healthy patients 2. The absence of periapical pathology 3. Not sensitive to articaine or epinephrine 4. No facial paresthesia 5. Not taking any analgesic drug 6 hours before treatment 6. Not taking any medication that interferes with anesthesia, such as tricyclic antidepressants and beta-blockers 7. The absence of pathosis in areas planned for injection 8. Not pregnant 9. The absence of pathologic periodontal pockets during probing 10. Patients with a mandibular first molar tooth exhibiting symptomatic irreversible pulpitis Exclusion Criteria: -

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Inferior Alveolar Nerve Block Group
A standard IANB injection with a conventional dental injector and a 27-G needle. After determining the injection site and performing aspiration, 1.8 mL of solution was injected at a rate of 1 mL/min to block the inferior alveolar nerve. After achieving lip anesthesia, infiltration was performed at the buccal side of the affected tooth with 0.5 mL using a normal syringe and a 27-G needle. The needle insertion point was the middle of the mesiodistal distance of the crown. Five minutes later, the teeth were isolated and the endodontic procedure was started.
Intraligamentary Injection Group
An infiltration was performed at the buccal side of the affected tooth with 0.5 mL using a normal syringe and a 27-G needle. Then, an intraligamentary injection was performed with a special pressure injection syringe (Sopira Citoject, Kulzer, Hanau, Germany) and a 30-G needle. The needle was placed alongside the tooth and inserted at a 30 angle relative to the longitudinal axis of the crown with the needle between the teeth and the bone. Then, in the mesiobuccal, distobuccal, mesiolingual and distolingual portions of teeth, 0.18 mL of the solution was injected. Five minutes later, the teeth were isolated and the endodontic procedure was started.

Locations

Country Name City State
Turkey Çukurova University, Faculty of Dentistry, Clinic of Endodontics Adana

Sponsors (1)

Lead Sponsor Collaborator
Cukurova University

Country where clinical trial is conducted

Turkey, 

References & Publications (2)

Habib MFOM, Tarek S, Teama SME, Ezzat K, El Boghdadi RM, Marzouk A, Fouda MY, Gawdat SI, Bedier MM, Amin SAW. Inferior alveolar nerve block success of 2% mepivacaine versus 4% articaine in patients with symptomatic irreversible pulpitis in mandibular molars: A randomized double-blind single-centre clinical trial. Int Endod J. 2022 Nov;55(11):1177-1189. doi: 10.1111/iej.13810. Epub 2022 Aug 20. — View Citation

Parirokh M, Yosefi MH, Nakhaee N, Manochehrifar H, Abbott PV, Reza Forghani F. Effect of bupivacaine on postoperative pain for inferior alveolar nerve block anesthesia after single-visit root canal treatment in teeth with irreversible pulpitis. J Endod. 2012 Aug;38(8):1035-9. doi: 10.1016/j.joen.2012.04.012. Epub 2012 May 30. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary The success of anesthesia techniques Heft-Parker visual analog scale (HPVAS) was used to evaluate the patient's subjective pain and convert it to quantitative values. The pain was classified as follows: 0, no pain as "1"; 1-54 mm, mild pain as "2"; 55-112 mm, moderate pain as "3"; and 114-170 mm, severe pain as "4".
If the VAS value is 1 and 2, anesthesia is considered successful, if 3 and 4, anesthesia is considered unsuccessful.
HPVAS-1 determines the VAS value of pain response to cold test. The VAS value of the pain response at the start of the treatment is HPVAS-2.
The VAS value of the pain response on entering the pulp chamber HPVAS-3:
The VAS value of the pain response during pulp extirpation was recorded as HPVAS-4.
0-2 hours
See also
  Status Clinical Trial Phase
Withdrawn NCT03318952 - Articaine vs Lidocaine for Pediatric Dental Procedures Phase 4
Completed NCT04317508 - Using Anesthetic Gel Patches to Reduce Pain of Palatal Injection Phase 1/Phase 2
Completed NCT00363207 - Behavior of Children Related to Numbness After Dental Local Anesthesia N/A
Completed NCT00309322 - Study of NV-101 for Safety and Efficacy in Pediatric Dental Patients Undergoing Procedures Phase 2
Completed NCT00309361 - Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients Undergoing Mandibular Procedures Phase 3
Completed NCT00309335 - Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients Undergoing Maxillary Procedures Phase 3
Completed NCT05423392 - Efficacy of 4% Articaine Terminal Anesthesia in the Lateral Jaw Region in Children N/A